Of note, Rb1 required both Nrf2 and PGC-1α to ameliorate diabetes-accelerated atherosclerosis in rodents without affecting metabolic parameters, suggesting that the benefit of Rb1 in diabetic atherosclerosis was independent of alterations in glucose and lipid metabolism. Here, PPARGC1A is linked to diabetes mellitus.